Notice: This company has been marked as potentially delisted and may not be actively trading. Akorn (AKRX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Akorn Reaches New 52-Week High (AKRX)May 15, 2023 | thestreet.comCarlin Consumer Health Names Scott Chapman Chief Executive Officer - Business WireOctober 20, 2022 | businesswire.comVeterinary Eye Care Market Size to record USD 788.78 Million Growth at a CAGR of 4.65% by 2026, Evolving Opportunities with Bausch Health Co Inc. And Akorn Operating Co. - Technavio - PR NewswireOctober 10, 2022 | prnewswire.comA small fund wagered that Elon Musk would be forced to buy Twitter—and made a killing by betting against the crowd - FortuneOctober 9, 2022 | fortune.comDiuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio - Yahoo FinanceSeptember 29, 2022 | finance.yahoo.comMoody's downgrades Akorn to Caa2; revises outlook to stable from positive - Moody'sSeptember 15, 2022 | moodys.comPrestige Consumer (PBH) Brands & E-commerce Strength Bode Well - NasdaqSeptember 2, 2022 | nasdaq.comThe Worldwide Inhalation & Nasal Sprays Generic Drugs Industry is Expected to Reach $11.2 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 29, 2022 | businesswire.comShort-sellers, lawyers, and academics predict the odds Elon Musk will be forced to close on a $44 billion deal he hates - FortuneAugust 27, 2022 | fortune.comThe Worldwide Glaucoma Treatment Industry is Expected to Reach $9.1 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 26, 2022 | businesswire.comConjunctivitis Market to Grow at a Healthy CAGR of 5.8% from 2022 to 2032 Owing to Growing Disease Prevalence Globally | Future Market Insights, Inc. - GlobeNewswireAugust 26, 2022 | globenewswire.comWhistleblower Claims Rattle Twitter's Bid To Force Musk Deal - Law360August 23, 2022 | law360.comAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - BloombergAugust 17, 2022 | bloomberg.comAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - PR NewswireAugust 16, 2022 | prnewswire.comPterygium Drug Market Trends, Shares, Key Players, Regional Overview and Market Is Growing At CAGR Of 6.2% By 2029 - GlobeNewswireAugust 11, 2022 | globenewswire.comDelaware Powerhouse: Paul Weiss - Law360August 5, 2022 | law360.comPrestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023 - StreetInsider.comAugust 4, 2022 | streetinsider.comThe Global Animal Sedative Market is expected to grow by $ 190.96 mn during 2022-2026, accelerating at a CAGR of 5.85% during the forecast period - Yahoo FinanceAugust 1, 2022 | finance.yahoo.comUM6P Ventures Invests in Akorn Technology to Reduce Global Food Waste - GlobeNewswireJuly 26, 2022 | globenewswire.comBleeding Disorders Treatment Market to Receive Irresistible Growth of USD 11.65 Billion by 2029 with Size, Share Global Industry Trends, Top Players and Revenue Analysis - PR NewswireJuly 20, 2022 | prnewswire.comIllinois Cases To Watch In 2nd Half Of 2022 - Law360July 14, 2022 | law360.comThe fight between Musk and Twitter will come down to 3 words—and they rarely work - FortuneJuly 11, 2022 | fortune.comAnalysis: Twitter has legal edge in deal dispute with Musk - Reuters.comJuly 9, 2022 | reuters.comPrestige Consumer (PBH) Brand-Building Efforts Solid, Costs High - NasdaqJune 14, 2022 | nasdaq.comThe Global Anaplastic Thyroid Cancer Drugs Market is expected to grow by $ 230.53 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period - Yahoo FinanceJune 10, 2022 | finance.yahoo.comGlobal Eye Drop (Prescription v/s Over-the-Counter) Markets, Analysis, Competition, Forecast and Opportunities, 2017-2021 & 2022-2027 - ResearchAndMarkets.com - Business WireJune 7, 2022 | businesswire.comElon Musk's Twitter Deal Has Become A Multibillion-Dollar Game Of Chicken - ForbesJune 7, 2022 | forbes.comGlobal Glaucoma Treatment Market Report (2022 to 2032) - Players Include Aerie Pharmaceuticals, Cipla, Abbvie and Akorn Operating Company - ResearchAndMarkets.com - Business WireMay 30, 2022 | businesswire.comGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Business WireMay 17, 2022 | businesswire.comGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Yahoo FinanceMay 17, 2022 | finance.yahoo.comElon Musk can't use Twitter bots to get out out of acquisition agreement - The Washington PostMay 14, 2022 | washingtonpost.comPrestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat - Yahoo FinanceMay 6, 2022 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022 - GlobeNewswireMay 5, 2022 | globenewswire.comWhat's in Store for Prestige Consumer (PBH) in Q4 Earnings? - NasdaqMay 4, 2022 | nasdaq.comGlobal eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027 - Yahoo FinanceMay 4, 2022 | finance.yahoo.comGlobal Antispasmodics Drugs Market Research Report to 2027 - Increasing Patient Awareness Level and Improvement in Treatment Presents Opportunities - ResearchAndMarkets.com - Business WireApril 23, 2022 | businesswire.comGlobal Veterinary Eye Care Market - Growth, Trends, and Forecasts (2022 - 2027) - ResearchAndMarkets.com - Yahoo FinanceApril 20, 2022 | finance.yahoo.comBronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio - Yahoo FinanceMarch 18, 2022 | finance.yahoo.comDry Eye Medication Global Market Report 2022 - Yahoo FinanceMarch 16, 2022 | finance.yahoo.comPrestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce - NasdaqMarch 14, 2022 | nasdaq.comWhy Is Model N (MODN) Down 6% Since Last Earnings Report? - NasdaqMarch 10, 2022 | nasdaq.comAkorn Announces Completion of the Sale of its Branded Ophthalmic Products to Théa Pharma - PR NewswireMarch 9, 2022 | prnewswire.comModel N Announces First Quarter Fiscal Year 2022 Financial Results - Yahoo FinanceFebruary 9, 2022 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - StreetInsider.comFebruary 3, 2022 | streetinsider.comPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - Yahoo FinanceFebruary 3, 2022 | finance.yahoo.comThéa to Acquire Branded Ophthalmic Products from Akorn, Expanding Théa's Presence into the U.S. Eye Care Industry - Business WireJanuary 28, 2022 | businesswire.comAkorn Announces Agreement to Sell its Branded Ophthalmic Products to Théa - PRNewswireJanuary 28, 2022 | prnewswire.comWhole Earth Brands (FREE) Appoints Duane Portwood as New CFO - StreetInsider.comJanuary 10, 2022 | streetinsider.comIndia Active Pharmaceutical Ingredients Market to surpass US$ 34,968.7 Million by 2028, Says Coherent Market Insights (CMI) - Yahoo FinanceDecember 24, 2021 | finance.yahoo.comInsights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others - Yahoo Finance UKDecember 16, 2021 | uk.finance.yahoo.com Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Grab This Altcoin Before Trump's Crypto Announcement (Ad)Under-the-Radar Crypto Could Soar by Jan. 20th Investors in the know could bank HUGE profits! Click HERE to access this free report AKRX Media Mentions By Week AKRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKRX News Sentiment▼0.000.65▲Average Medical News Sentiment AKRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKRX Articles This Week▼00▲AKRX Articles Average Week Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKRX) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akorn, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akorn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
